COVID19
Clinical trials for COVID19 explained in plain language.
Never miss a new study
Get alerted when new COVID19 trials appear
Sign up with your email to follow new studies for COVID19, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
COVID-19 antibody trial halted: did it help severe cases?
Disease control TerminatedThis study tested an experimental antibody drug called SCTA01 in adults hospitalized with severe COVID-19. The goal was to see if the drug could help patients recover faster compared to a placebo. The trial was stopped early, and only 102 people took part, so the results are limi…
Matched conditions: COVID19
Phase: PHASE2, PHASE3 • Sponsor: Sinocelltech Ltd. • Aim: Disease control
Last updated May 26, 2026 05:39 UTC
-
Stem cell COVID trial halted early – what happened?
Disease control TerminatedThis study tested whether stem cells from donated umbilical cords could help hospitalized adults with severe COVID-19 avoid needing a breathing tube or dying. Nineteen participants received either the stem cells or a placebo, plus standard care. The trial was stopped early, so re…
Matched conditions: COVID19
Phase: PHASE2 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated May 26, 2026 05:30 UTC
-
COVID-19 drug study in kids halted early
Disease control TerminatedThis study aimed to see if the drug baricitinib is safe and works in children aged 1 to 18 hospitalized with COVID-19. Only 6 children took part before the study was stopped early. The goal was to find the right dose and check how the drug moves through the body.
Matched conditions: COVID19
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
Ancient remedy meets modern virus: TCM granules tested in COVID-19 pilot
Symptom relief TerminatedThis pilot study tested whether a traditional Chinese medicine called Xuanfei Baidu granules is safe and acceptable for people with mild to moderate COVID-19. Only 10 adults aged 18 to 75 with confirmed COVID-19 were enrolled. The main goal was to see how many people agreed to jo…
Matched conditions: COVID19
Phase: PHASE2 • Sponsor: Darcy Spicer • Aim: Symptom relief
Last updated May 22, 2026 13:50 UTC
-
Arthritis meds and COVID: do they weaken your immune defense?
Knowledge-focused TerminatedThis study looked at whether immunosuppressive medications used for rheumatoid arthritis or spondyloarthritis change how the body handles a COVID-19 infection. Researchers compared 150 patients on these drugs with infected family members not on the same treatments. The goal was t…
Matched conditions: COVID19
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 26, 2026 05:39 UTC
-
New brain scanner aims to uncover COVID-19's hidden neurological impact
Knowledge-focused TerminatedThis study tested a new brain imaging device that combines PET and MRI scans to look at brain function and structure in people who have had COVID-19. The goal was to see if the device could produce clear images of brain metabolism and blood flow, helping researchers understand ne…
Matched conditions: COVID19
Phase: NA • Sponsor: Stanford University • Aim: Knowledge-focused
Last updated May 26, 2026 05:37 UTC
-
Smart vest tracks COVID-19 trends in hospital patients
Knowledge-focused TerminatedThis study tested a special wearable vest that tracks health data in people hospitalized with COVID-19. The goal was to see if the vest could collect useful information and help spot when a patient's condition gets worse. Only 15 people took part before the study was stopped earl…
Matched conditions: COVID19
Sponsor: Nanowear Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 05:30 UTC
-
Eye scans reveal hidden COVID-19 damage?
Knowledge-focused TerminatedThis study aimed to collect eye scans from people who had COVID-19 to see if the virus caused damage to the retina, the light-sensitive part of the eye. Researchers compared patients who had severe COVID-19 with those who had mild cases. The study was stopped early and included 2…
Matched conditions: COVID19
Sponsor: Centre Hospitalier Intercommunal Creteil • Aim: Knowledge-focused
Last updated May 07, 2026 18:39 UTC